- EMEA Innovative Medicine
- About us
- Our responsibilities
- To healthcare professionals
Our responsibility to healthcare professionals
Our approach to continuous professional development
We invest in education programmes, materials and events, making them part of the responsibility for the medicines we develop. This work contributes to the enhancement of medical practice by increasing knowledge about diseases and the latest standards of care.
We invest in education programmes, materials and events, making them part of the responsibility for the medicines we develop. This work contributes to the enhancement of medical practice by increasing knowledge about diseases and the latest standards of care.
Partnering for lifelong learning in healthcare
We contribute to the high quality education in partnership with the medical community, and ensure that important new medical advances are discussed in a variety of settings, from international congresses to smaller educational meetings. Strict principles and compliance requirements ensure we set out clear procedures on interactions with individual healthcare professionals, as well as those with medical societies and institutions.
The three types of medical education activities
Congress attendance
The educational meetings we support must foster scientific exchange and disseminate the latest standard of care to facilitate safe and effective treatment for patients. Some of these meetings are accredited by accreditation bodies and some are not. At J&J Innovative Medicine we apply the same quality rules to both
We follow the EFPIA code of practice: Article 16 for Medical Education activities. Locally, J&J Innovative Medicine follows national events accreditation and local rules and codes of practice, including any applicable endorsement if required by Health Authorities.
We provide financial support in the form of grants and sponsorships to major national and European congresses because of the role they play in the dissemination of important medical advances.
We follow the EFPIA code of practice: Article 16 for Medical Education activities. Locally, J&J Innovative Medicine follows national events accreditation and local rules and codes of practice, including any applicable endorsement if required by Health Authorities.
We provide financial support in the form of grants and sponsorships to major national and European congresses because of the role they play in the dissemination of important medical advances.
Medical education programmes
We support medical educational events and activities, organised with independent experts according to strict principles. We base our policy on the Article 16 of the EFPIA Code of Practice, as well as on local regulations and codes of practice, depending on which are stricter.
Meetings are non-promotional
All educational meetings are managed by our Medical Affairs department which is separate from the commercial side of our business. These educational meetings do not focus on a single drug but disease areas. Medicine brand names are not used and any discussion about specific treatments has to be balanced and factual.
Meetings are non-promotional
All educational meetings are managed by our Medical Affairs department which is separate from the commercial side of our business. These educational meetings do not focus on a single drug but disease areas. Medicine brand names are not used and any discussion about specific treatments has to be balanced and factual.
Individual support
In many countries, authorities require healthcare professionals to keep up to date with medical advances through continued education, but often do not support postgraduate medical education.
Along with other pharmaceutical companies, we take part of the responsibility here. Our selection process is transparent and is based on doctors’ educational needs or active involvement in a particular meeting or event.
Any individual support is, of course, subject to local regulations, such as required notification to health authorities or contribution by the individual doctor.
Along with other pharmaceutical companies, we take part of the responsibility here. Our selection process is transparent and is based on doctors’ educational needs or active involvement in a particular meeting or event.
Any individual support is, of course, subject to local regulations, such as required notification to health authorities or contribution by the individual doctor.
J&J Medical Cloud
Janssen Medical Cloud is a dedicated platform designed exclusively for healthcare professionals, offering an innovative approach to support and enhance their clinical practice, their knowledge, and to provide the best care for their patients.
How our medical education work is regulated and disclosed
Our approach ensures we meet expectations of transparent and unbiased lifelong learning in healthcare, whilst fostering scientific exchange and knowledge dissemination to ensure the best treatment outcomes for patients.
In addition to the criteria outlined above, we have strict rules to ensure our educational support does not constitute undue influence.
In addition to the criteria outlined above, we have strict rules to ensure our educational support does not constitute undue influence.
Logistics
Hotels are business venues (and under no circumstances are they luxury or entertainment venues), and flights are economy, unless the duration exceeds six hours – if local rules permit. There are limits on the amount which can be spent on food and drink too, based on local pharmaceutical association hospitality limits.
Service fees
We pays a token amount when requesting services such as speaker engagement, serving on advisory boards or developing educational materials. Fees are calculated based on the time dedicated to providing the service, as advised by independent sources.
Transparency
Since June 2016, we annually publish the transfers of value made to healthcare professionals and healthcare organizations, according to the EFPIA Disclosure Code and national Industry Association guidelines or national regulations, as appropriate.